EyePoint Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
EyePoint Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2011 to Q2 2024.
  • EyePoint Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $8.7M, a 386% increase year-over-year.
  • EyePoint Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $28.6M, a 151% increase year-over-year.
  • EyePoint Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $12.1M, a 15% decline from 2022.
  • EyePoint Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $14.2M, a 90.4% increase from 2021.
  • EyePoint Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $7.45M, a 34.3% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $28.6M $8.7M +$6.91M +386% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $21.7M $12.7M +$9.65M +316% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $12.1M $3.59M +$229K +6.81% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 $11.8M $3.63M +$430K +13.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $11.4M $1.79M -$2.35M -56.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $13.8M $3.05M -$427K -12.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $14.2M $3.36M +$553K +19.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 $13.6M $3.2M +$728K +29.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $12.9M $4.14M +$2.96M +251% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $9.94M $3.48M +$2.49M +252% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $7.45M $2.81M +$1.55M +122% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q3 2021 $5.9M $2.47M +$82K +3.43% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $5.82M $1.18M +$445K +60.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $5.38M $988K -$172K -14.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $5.55M $1.26M +$406K +47.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 $5.14M $2.39M +$1.41M +145% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $3.73M $735K -$761K -50.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $4.49M $1.16M -$78K -6.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $4.57M $857K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-12
Q3 2019 $977K -$420K -30.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $1.5M +$522K +53.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $1.24M +$795K +179% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q3 2018 $3.42M $1.4M +$716K +105% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $2.7M $974K +$292K +42.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $2.41M $443K -$201K -31.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $2.61M $606K +$210K +53% Oct 1, 2017 Dec 31, 2017 10-Q 2018-02-08
Q3 2017 $2.4M $681K -$53K -7.22% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $2.46M $682K +$68K +11.1% Apr 1, 2017 Jun 30, 2017 10-K 2020-03-16
Q1 2017 $2.39M $644K -$17K -2.57% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $2.41M $396K -$87K -18% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-08
Q3 2016 $2.49M $734K +$329K +81.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $2.16M $614K -$7K -1.13% Apr 1, 2016 Jun 30, 2016 10-KT 2019-03-18
Q1 2016 $2.17M $661K +$47K +7.66% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 $2.12M $483K +$66K +15.8% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-09
Q3 2015 $2.06M $405K +$96K +31.1% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $1.96M $621K +$173K +38.6% Apr 1, 2015 Jun 30, 2015 10-K 2017-09-13
Q1 2015 $1.79M $614K +$173K +39.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $1.62M $417K +$112K +36.7% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 $1.5M $309K +$92K +42.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $1.41M $448K +$49K +12.3% Apr 1, 2014 Jun 30, 2014 10-K 2016-09-13
Q1 2014 $1.36M $441K +$129K +41.3% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $1.23M $305K +$42K +16% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-06
Q3 2013 $1.19M $217K -$126K -36.7% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $1.32M $399K +$9K +2.31% Apr 1, 2013 Jun 30, 2013 10-K 2015-09-10
Q1 2013 $1.31M $312K -$67K -17.7% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 $1.38M $263K +$98K +59.4% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-12
Q3 2012 $1.28M $343K -$134K -28.1% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 $1.41M $390K Apr 1, 2012 Jun 30, 2012 10-K 2013-09-27
Q1 2012 $379K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q4 2011 $165K Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-08
Q3 2011 $477K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.